Prestige Consumer Healthcare Inc
PBH: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| Vmt | LOCK|&Ty$ | LOCK|!$<#&# |
Prestige Earnings: Clear Eyes Recovery Gradually Coming Into View
Prestige reported fiscal third-quarter revenue of $283.4 million, down 2.4% year over year, and adjusted EPS of $1.14. Shares fell 2% as management guided full-year results toward the lower end of its prior range, projecting revenue of approximately $1.1 billion and adjusted EPS of $4.54.
